SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Matritech (NASDAQ - NMPS)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Nelson Chang who wrote (106)7/12/1996 9:10:00 AM
From: eugenic1   of 849
 
NMP-22 US approval will impact earnings in 3rd qtr.
Urocor reps will be selling kits with a vengeance. I would not be surprised
if nmps showed black in 3rd qtr. It is hard to call it selling. Imagine
telling managed care providers that FDA just approved the test that
is more than twice as accurate, noninvasive, and cost the patient or
his ins. co. 1/6 as much. This is not selling. This is a slam dunk
contest. This technology will blossom with kits for the other cancers
as they have discussed and will become the standard.
Management has made some savvy moves imo. ie:stock offering near or
about the anticipated time of fda approval. They do not need the $,
but if demand for shares was strong, what the hell. Market at time of
announcement was very unstable, so stock did not run for days as it should
have. They used practically every wire service known to make the FDA
announcement, unlike other co's I know. Sometimes I wonder if co's
want news to stay a secret. Yesterday afternoon, they withdrew offering
@3:30 to give depressed price a jolt.
This co's share price will firm up and begin a rise on fundamentals
I would guess 2nd qtr #'s will be out early AUG, if not sooner,based
on CHubb's words. He mentioned a trend, 3rd qtr will be the head snapper.
Co. will show profit soon.
best returns
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News